Japan, Jan. 28 -- HARBOUR BIOMED (SHANGHAI) CO LTD has got intellectual property rights for 'CD3-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF.' Other related details are as follows:
Application Number: JP,2024-000181
Category (FI): C12N15/85@Z,C12N15/63@Z,C12N1/21,C12N1/15,C12N1/19,A61K35/12,A61K48/00,A61K39/395@U,A61K39/395@T,A61P35/00,C12N5/10,C07K16/28,C07K16/46,C12N15/13,C12N15/62@Z
Stage: Grant (IP right document published.)
Filing Date: Jan. 4, 2024
Publication Date: March 15, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....